|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||98.50 - 98.50|
|52-week range||88.75 - 112.65|
|Beta (5Y monthly)||0.40|
|PE ratio (TTM)||18.11|
|Forward dividend & yield||3.86 (3.92%)|
|Ex-dividend date||05 May 2021|
|1y target est||N/A|
Dr. James Simmons, Hospitalist Nurse Practitioner in Los Angeles, CA, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics PARIS – September 14, 2021 - Sanofi announced today the completion of its acquisition of Translate Bio, further accelerating the company’s efforts to develop transformative vaccines and therapies using mRNA technology. The acquisition adds a critical pillar to the company’s mRNA Center of Excellence which aims to unlock the potential of next-generation mRNA vaccines and other stra
Dr. Susannah Hills, Pediatric Airway Surgeon and Assistant Professor of ENT at Columbia University Medical Center, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.